Locally advanced non-small cell lung cancer (NSCLC) stage IIIA/IIIB represe
nts approximately 30% of NSCLC and still has a poor prognosis. In this arti
cle we give a short review on several randomized phase III trials that show
ed a slight but significant survival benefit for sequential chemo-radiother
apy in the treatment of locally advanced NSCLC. (C) 2001 Published by Elsev
ier Science Ireland Ltd.